Personalis, Inc. (PSNL)
6.31
+0.29
(+4.82%)
USD |
NASDAQ |
Apr 13, 16:00
6.32
+0.01
(+0.16%)
After-Hours: 07:07
Personalis Cash from Investing (TTM) : -22.57M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 228.03M |
| Celldex Therapeutics, Inc. | 209.07M |
| Plus Therapeutics, Inc. | -0.854M |
| Atossa Therapeutics, Inc. | -0.023M |
| Abeona Therapeutics, Inc. | 105.03M |